Physician profile
Michael Miller
NPI 1629482724
$2,034.46
in general payments reported to CMS, 2019-2025
17 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $268 · 2020: $84.25 · 2021: $171 · 2022: $426 · 2023: $423 · 2024: $463 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,085.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $518.75 | 2019-2025 | Precision 1, Precision7, Dailies |
| Coopervision INC. | $357.65 | 2020-2025 | Myday Contact Lens |
| Oyster Point Pharma, INC. | $255.03 | 2022-2024 | Tyrvaya, Ryzumvi |
| Abbvie INC. | $201.99 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $161.62 | 2024-2025 | Xdemvy |
| Lkc Technologies, INC. | $107.63 | 2024 | |
| Carl Zeiss Meditec, INC. | $98.16 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $86.77 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $68.75 | 2022-2025 | Infuse, Btod |
| Horizon Therapeutics Plc | $31.27 | 2021-2023 | Tepezza |
| Lombart Brothers, INC. | $28.41 | 2024 | Opd-III |
| Allergan, INC. | $27.05 | 2021 | |
| Sun Pharmaceutical Industries INC. | $24.89 | 2020 | |
| Kala Pharmaceuticals, INC. | $20.29 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.76 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.95 | 2019 | |
| Mallinckrodt Hospital Products INC. | $13.49 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.